Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 540,500 shares at $48.56 ($25.0M) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $25.0M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.72 | 65,820 | $2.9M | 11.8% |
| 2 | $44.72 | 65,820 | $2.9M | 11.8% |
| 3 | $45.53 | 89,888 | $4.1M | 16.4% |
| 4 | $45.53 | 89,888 | $4.1M | 16.4% |
| 5 | $46.52 | 49,082 | $2.3M | 9.1% |
| 6 | $46.52 | 49,082 |
| $2.3M |
| 9.1% |
| 7 | $47.69 | 23,003 | $1.1M | 4.4% |
| 8 | $47.69 | 23,003 | $1.1M | 4.4% |
| 9 | $48.56 | 42,457 | $2.1M | 8.3% |
| 10 | $48.56 | 42,457 | $2.1M | 8.3% |
| Total | $46.17 avg | 540,500 | $25.0M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $8.9M | — | Filing → |